Competitive inhibition of reagin-mediated histamine release by a human IgG2 myeloma protein.
D000478:Alkylation; D000818:Animals; D001666:Binding Sites, Antibody; D001667:Binding, Competitive; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007073:Immunoglobulin E; D007074:Immunoglobulin G / Q000494:pharmacology*; D007158:Immunologic Techniques; D008168:Lung / Q000276:immunology; D008251:Macaca / Q000276:immunology; D009194:Myeloma Proteins / Q000302:isolation & purification / Q000494:pharmacology*; D010084:Oxidation-Reduction; D010323:Passive Cutaneous Anaphylaxis; D010954:Plasmacytoma / Q000276:immunology; D011863:Radioimmunoassay; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology; D012882:Skin Tests
D007106:Immune Sera; D007074:Immunoglobulin G; D009194:Myeloma Proteins; D007073:Immunoglobulin E